JANE STREET GROUP, LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 113 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2024$628,500
+452.2%
203,398
+361.0%
0.00%
Q1 2024$113,827
-52.8%
44,119
-54.3%
0.00%
Q4 2023$241,272
-41.6%
96,509
-29.2%
0.00%
Q1 2023$412,952
+66.3%
136,288
+27.9%
0.00%
Q4 2022$248,253
+589.6%
106,546
+464.7%
0.00%
Q3 2022$36,000
-68.7%
18,869
-55.7%
0.00%
Q2 2022$115,000
-91.1%
42,601
-90.2%
0.00%
Q1 2022$1,296,000
-60.6%
434,714
-48.6%
0.00%
Q4 2021$3,293,000
+66.6%
846,380
+83.7%
0.00%
Q3 2021$1,977,000
+924.4%
460,861
+624.2%
0.00%
Q2 2021$193,000
-63.8%
63,635
-60.3%
0.00%
Q1 2021$533,000
-45.1%
160,362
-41.4%
0.00%
Q4 2020$971,000
+1732.1%
273,464
+1525.3%
0.00%
Q3 2020$53,000
-72.7%
16,825
-84.2%
0.00%
Q2 2020$194,000
+165.8%
106,181
+45.6%
0.00%
Q1 2020$73,000
-79.0%
72,925
-56.4%
0.00%
-100.0%
Q2 2019$348,000
+411.8%
167,188
+1422.2%
0.00%
Q3 2017$68,000
-56.1%
10,983
-56.7%
0.00%
-100.0%
Q3 2015$155,00025,3740.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 2,651,825$19,358,0006.60%
RTW INVESTMENTS, LP 5,165,499$37,708,0002.72%
Eversept Partners, LP 97,495$711,7140.33%
Seelaus Asset Management LLC 14,300$104,0000.09%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,765,315$8,827,0000.08%
ALGERT GLOBAL LLC 34,816$254,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 48,000$350,0000.03%
OXFORD ASSET MANAGEMENT LLP 211,115$1,540,0000.03%
PRIMECAP MANAGEMENT CO/CA/ 4,000,400$29,203,0000.02%
PDT Partners, LLC 66,965$489,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders